trond aasen
Vall d'Hebron Research Institute (VHIR)
Barcelona, Spain
Community Reviewer
Cancer Molecular Targets and Therapeutics
Vall d'Hebron Research Institute (VHIR)
Barcelona, Spain
Community Reviewer
Cancer Molecular Targets and Therapeutics
University of Rome Tor Vergata
Roma, Italy
Community Reviewer
Cancer Molecular Targets and Therapeutics
Isfahan University of Medical Sciences
Isfahan, Iran
Community Reviewer
Cancer Molecular Targets and Therapeutics
Ege University
Bornova, Türkiye
Community Reviewer
Cancer Molecular Targets and Therapeutics
Adiyaman University
Adıyaman, Türkiye
Community Reviewer
Cancer Molecular Targets and Therapeutics
University of Baghdad
Baghdad, Iraq
Community Reviewer
Cancer Molecular Targets and Therapeutics
School of Medicine, Yale University
New Haven, United States
Community Reviewer
Cancer Molecular Targets and Therapeutics
University of Texas Southwestern Medical Center
Dallas, United States
Community Reviewer
Cancer Molecular Targets and Therapeutics
Cancer Science Institute of Singapore, National University of Singapore
Singapore, Singapore
Community Reviewer
Cancer Molecular Targets and Therapeutics
University of Turin
Turin, Italy
Community Reviewer
Cancer Molecular Targets and Therapeutics
Rhode Island Hospital
Providence, United States
Community Reviewer
Cancer Molecular Targets and Therapeutics
University of Texas MD Anderson Cancer Center
Houston, United States
Community Reviewer
Cancer Molecular Targets and Therapeutics
University of Florence
Florence, Italy
Community Reviewer
Cancer Molecular Targets and Therapeutics
Jeju National University
Jeju City, Republic of Korea
Community Reviewer
Cancer Molecular Targets and Therapeutics
National Autonomous University of Mexico
México City, Mexico
Community Reviewer
Cancer Molecular Targets and Therapeutics
Fox Chase Cancer Center
Philadelphia, United States
Community Reviewer
Cancer Molecular Targets and Therapeutics